They demonstrated again that TIM3 expression on the surface of primitive cells and plasma levels of the TIM3 ligand, galactoselectin-9 (Gal-9), are dynamically elevated with the transformation of MDS to AML and are closely associated with primitive cell proliferation, disease progression, and prognosis (27). This evidence concerns the gene LGALS9 and acute myeloid leukemia.